Randomized Evaluation of Bromocriptine in Myocardial Recovery Therapy (REBIRTH) for Peripartum Cardiomyopathy (Pregnancy)
Sponsor: |
NIH |
Enrolling: |
Female Patients Only |
IRB Number: |
AAAU2889 |
U.S. Govt. ID: |
NCT05180773 |
Contact: |
Jennifer Haythe: / jhh28@cumc.columbia.edu |
We are doing this study to test the use of a drug called bromocriptine for women with a condition called Peripartum cardiomyopathy (PPCM). The study will look at how the heart muscle improves in women taking bromocriptine compared to a group of women given a placebo or inactive pill.
Investigator
Jennifer Haythe, MD
Have you been diagnosed with peripartum cardiomyopathy? |
Yes |
No |
Are you in the last month of your pregnancy or the first 5 months postpartum? |
Yes |
No |